There are no proven peptides for ADHD. No peptide is approved for attention-deficit/hyperactivity disorder, and none has been tested in a published randomized ADHD trial. Interest in Semax comes from a 2007 hypothesis paper and rodent studies,[4][5] Cerebrolysin from one small uncontrolled Russian report in children,[6] and oxytocin from an 8-child pilot study.[7] By contrast, approved ADHD medicines have been tested in more than 130 randomized trials.[2]
This guide grades what exists. For more on brain-focused compounds, see our nootropic peptides hub.
Evidence at a glance
| Peptide or treatment | Evidence level | What was shown | FDA status | Our profile |
|---|---|---|---|---|
| Stimulants and non-stimulant ADHD medicines | FDA-approved for this use | All beat placebo on core symptoms in 133 trials[2] | Approved (not peptides) | n/a |
| Behavioral treatment and parent training | Human RCTs | Recommended first for preschoolers[1] | Not a drug | n/a |
| Oxytocin (nasal) | Small human studies | Faster responses on social tasks in 8 children[7] | Approved only for labor and postpartum bleeding | Oxytocin |
| Cerebrolysin | Small human studies (uncontrolled) | Immune and neurological changes reported in one report[6] | Not approved | Cerebrolysin |
| Semax | Animal or lab only | Boosted amphetamine’s dopamine effect in rodents[5] | Not approved | Semax |
| Selank | No evidence, marketing only | No ADHD studies found | Not approved | Selank |
| Dihexa, P21 | No evidence, marketing only | No ADHD studies found | Not approved | Dihexa, P21 |
Start with what works
The American Academy of Pediatrics recommends behavioral treatment, such as parent training, as the first step for preschool children with ADHD. For school-age children and teens, it recommends FDA-approved ADHD medicines together with behavioral and school support.[1] More broadly, standard ADHD treatment includes medication and psychosocial approaches such as cognitive behavioral therapy.[3]
The evidence behind these medicines is large. A 2018 analysis of 133 double-blind trials, covering more than 10,000 children and 8,000 adults, found every studied drug beat placebo on clinician-rated symptoms. Weighing benefits against side effects, the authors favored methylphenidate for children and teens and amphetamines for adults as first choices.[2]
If those options have not worked or cause side effects, the next step is a medicine review with your prescriber, not an untested peptide.
Semax: an idea, not a treatment
Semax is a nasal peptide based on a fragment of the hormone ACTH. It is prescribed in Russia, mostly for stroke.[8]
- In rodents, Semax alone did not change dopamine levels, but given before amphetamine it strongly increased amphetamine’s effect on dopamine release and movement.[5]
- A 2007 paper proposed Semax for ADHD based on such animal work. It was a hypothesis, with no patients studied.[4]
No ADHD trial of Semax has been published. The rodent finding also raises a practical question nobody has studied: what happens when Semax is combined with a prescribed stimulant. FDA staff reviewed Semax in 2026 and recommended against adding it to the list of substances pharmacies may compound.[8]
Selank: no ADHD data
Selank is sold in Russia as a nasal anxiety medicine.[9] Its human studies are small and involve adults with anxiety. We found no studies of Selank in ADHD, in children or adults. See best peptides for anxiety for what is known.
Cerebrolysin: one old, uncontrolled report
Cerebrolysin is an injected peptide mix made from pig brain. A 2002 Russian paper described children with ADHD given intramuscular Cerebrolysin for one month. The authors reported improvements in neurological and immune measures and fewer infections, but there was no placebo group and the focus was immune markers, not ADHD symptom scales.[6] That cannot show whether it helps ADHD.
Oxytocin: an 8-child pilot
Oxytocin is a hormone approved in the US only as an injection for labor and postpartum bleeding. In a 2026 pilot crossover study, 8 children with ADHD received single nasal doses of oxytocin or placebo. Reaction times and consistency on social-thinking tasks improved, with no adverse events reported. The authors called the results preliminary.[7] The study did not measure attention or hyperactivity as a treatment outcome.
Why people look at peptides for ADHD
Some people turn to peptides because stimulants cause side effects such as poor appetite or trouble sleeping, because of stimulant shortages, or because they want something marketed as “natural.” Online sellers often describe Semax and Selank as focus or “nootropic” peptides, borrowing language from Russian studies in other conditions. Those studies were not in ADHD, and a product’s popularity is not evidence that it works.
If side effects or access are the problem, there are proven alternatives to discuss: a different stimulant, a lower dose, a long-acting form, or a non-stimulant medicine. The 2018 analysis found non-stimulants such as atomoxetine also beat placebo in children.[2]
Safety concerns with “focus peptides”
- Unknown purity: European drug-control labs found Selank and Semax in seized products and noted these peptides are sold online as powders and nasal sprays without completed clinical trials.[10]
- No pediatric data: none of these peptides has dosing or safety data in children with ADHD.
- Regulatory status: none is FDA-approved, and FDA lists several research peptides, including Dihexa, among compounding substances that raised safety concerns.[11]
- Delay in care: untreated ADHD affects school, work and safety. Time spent on unproven products can delay treatment that works.
A note for adults with ADHD
Adults are the main audience for “focus peptide” marketing, often framed as a way to boost productivity without a prescription. The evidence gap is the same: no adult ADHD trial of Semax, Selank, Dihexa or any similar peptide has been published. Adults with ADHD have well-studied options, including amphetamine-based medicines, methylphenidate, non-stimulants and therapies such as cognitive behavioral therapy.[2][3]
If you already take an ADHD medicine and are thinking about adding a peptide, tell your prescriber first. The rodent data showing that Semax amplifies amphetamine’s effect on dopamine is a reason for caution, not reassurance.[5]
Questions to ask your clinician
- Is the current dose or medicine the right fit, and are there alternatives?
- Would behavioral therapy, coaching or school accommodations help?
- Could any supplement or peptide interact with my ADHD medicine?
For related reading, see Selank vs Semax, best peptides for cognition and peptides for autism.
